Magnetic and Structural Transitions at Dimerization of C₆₀^•− in Ionic Fullerene Complexes with Metalloporphyrins: {(TMP⁺)₂·M<sup>II</sup... by Dmitri V. Konarev (1405348)

“…Dimerization in <b>2</b> results in a decrease in the magnetic moment from 6.36 to 6.00 μ_B at 200−150 K and a change in the shape of EPR signal. …”

Magnetic and Structural Transitions at Dimerization of C₆₀^•− in Ionic Fullerene Complexes with Metalloporphyrins: {(TMP⁺)₂·M<sup>II</sup... by Dmitri V. Konarev (1405348)

“…Dimerization in <b>2</b> results in a decrease in the magnetic moment from 6.36 to 6.00 μ_B at 200−150 K and a change in the shape of EPR signal. …”

Magnetic and Structural Transitions at Dimerization of C₆₀^•− in Ionic Fullerene Complexes with Metalloporphyrins: {(TMP⁺)₂·M<sup>II</sup... by Dmitri V. Konarev (1405348)

“…Dimerization in <b>2</b> results in a decrease in the magnetic moment from 6.36 to 6.00 μ_B at 200−150 K and a change in the shape of EPR signal. …”

Data_Sheet_1_rdHSV-CA8 non-opioid analgesic gene therapy decreases somatosensory neuronal excitability by activating Kv7 voltage-gated potassium channels.docx by Munal B. Kandel (18526539)

“…This study tested the hypothesis that novel JDNI8 replication-defective herpes simplex-1 viral vectors (rdHSV) carrying a CA8 transgene (vHCA8) reduce primary afferent neuronal excitability. …”

Table_1_Decreased circulating dipeptidyl peptidase-4 activity after short-term intensive insulin therapy predicts clinical outcomes in patients with newly diagnosed type 2 diabetes... by Jie Chen (5892)

“…After three months post-SIIT, DPP-4 activity remained stable in the remission group (39.63 ± 8.53 nmol/L) but increased in the non-remission group (42.34 ± 6.64 nmol/L). This resulted in a more pronounced decrease in DPP-4 activity from baseline in the remission group (-3.39 ± 8.90 vs. -1.10 ± 8.95, P = 0.035). …”

Transitioning of people with T1D from Multiple Daily Injections (MDI) and Self-Monitoring of Blood Glucose (BGM) directly to MiniMed™ 780G Advanced Hybrid Closed Loop (AHCL) system... by Bartłomiej Matejko (13180606)

“…</p> <p>Results: 41 participants were recruited and randomized to either the AHCL (20) or the MDI+BGM (21) group. 37 participants (age 40.3±8.0 years; duration of diabetes 17.3 ± 12.1 years; BMI 25.1±3.1 kg/m2; HbA1c 7.2% ± 1.0) completed the study. Time spent in target (TIR) increased from 69.3±12.3% at baseline to 85.0±6.3% at 3 months in the AHCL group, while remaining unchanged in the control group: treatment effect 21.5% [95% CI 15.7, 27.3%]; p < 0.001. …”

After the injection of PAM, the level of PPARγ increases, and the expression of TGFβ1/SMAD3 decreases, thereby inhibiting EMT and improving intestinal fibrosis. (A) Changes in the mRNA expression level of E-cadherin. (B) Changes in the mRNA expression level of N-cadherin. (C) Changes in the mRNA expression level of V-cadherin. (D) Changes in the mRNA expression level of COL1A1.... by Yi You (2567890)

“…(C) Changes in the mRNA expression level of V-cadherin. (D) Changes in the mRNA expression level of COL1A1. …”

IL-1Ra ASO treatment in HFD-fed obese mice results in decreased body weight (A) despite similar food intake (B) (food intake measured weekly and presented as average food intake ov... by Niclas Franck (632562)

Background comparison of relative abundance of 12 most abundant taxa. by John B. O’Connor (11529852)

Supplementary Material for: Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and In... by Li Q. (2850350)

Flow diagram of participant selection. by Prajwal Paudel (7359209)

“…Lack of exposure to ACS was associated with higher odds of prolonged hospital stay (aOR: 3.321, 95% CI: 1.957–5.638) and mortality (aOR: 5.731, 95% CI: 3.199–10.266).…”

Supplementary file ACS. by Prajwal Paudel (7359209)

“…Lack of exposure to ACS was associated with higher odds of prolonged hospital stay (aOR: 3.321, 95% CI: 1.957–5.638) and mortality (aOR: 5.731, 95% CI: 3.199–10.266).…”

Decreasing <i>VCP</i> function increases the activation of the Ire1/Xbp1 UPR pathway in <i>Rh1^P37H</i>-expressing flies. by Ana Griciuc (243073)

TBL comparison. by John B. O’Connor (11529852)

Involvement of COX-2/PGE2 signaling in proliferation of A549 cells. by Erina Takai (465811)

“…Each value represents the mean ± SE (n = 5-7) (C) Treatment with AH6809 (30 µM), L798106 (30 µM) or L161982 (30 µM) for 3 days suppressed proliferation of A549 cells. …”

pGenesil-siSurvivin and pGenesil-shiHBV4 have synergistic effects in decreasing the survivin protein level and inducing apoptosis of HepG2.2.15 cells. by Jingwei Ma (125700)

Universal expression of a Bmpr2 mutation that impacts Smad signaling results in a pulmonary inflammatory phenotype (A) Rosa26-Bmpr2^delx4+ transgenic mice have a decrease... by Megha Talati (548678)

Dataset_Plos_weighting_def - by Jesús Martín-Fernández (406234)

“…The probability of reporting a “very good” health condition decreased with a diagnosis of hypertension (6.2%; CI 95%: 3.1–9.3%) and hypertensive medication (4.5%; CI 95%: 1.8–7.3%). …”

Targeting of Alpha-V Integrins Reduces Malignancy of Bladder Carcinoma by Geertje van der Horst (458926)

“…<div><p>Low survival rates of metastatic cancers emphasize the need for a drug that can prevent and/or treat metastatic cancer. αv integrins are involved in essential processes for tumor growth and metastasis and targeting of αv integrins has been shown to decrease angiogenesis, tumor growth and metastasis. …”

Supplemental Figure S2 from Evolutionary Action Score of <i>TP53</i> Identifies High-Risk Mutations Associated with Decreased Survival and Increased Distant Metastases in Head and... by David M. Neskey (14920268)